Consequences, Molecular Mechanisms and Possible Treatments
E-Book, Englisch, 462 Seiten, eBook
ISBN: 978-3-7091-1125-3
Verlag: Springer Wien
Format: PDF
Kopierschutz: 1 - PDF Watermark
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Foreword.- Introduction. Leishmaniasis, the biology of a parasite.
Alicia Ponte Sucre
.- I Determinant features in leishmaniasis.- 1 Molecular evolution and phylogeny of Leishmania.
Gabriele Schoenian
,
Elisa Cupolillo, Isabel Mauricio
.- 2 The role of reservoirs: Canine leishmaniasis.
Lenea Campino, Carla Maia
.- 3 Epidemiology of leishmaniasis in the time of drug resistance.
Jean Claude Dujardin, Saskya Decuypere
.- II
Leishmania
and the immune system.- 4 The role of the immune system in resistance to infection.
Lukasz Kedzierski, Krystal J. Evans
.- 5 Vaccination as a control measure.
Katrin Färber , Heidrun Moll.-
6 Leishmania vaccines: Past, Present and Future.
Bhavana SethuLakshmi,RentalaMadhubala.-
III Challenges in the diagnosis, treatment and control of leishmaniasis in times of drug resistance.- 7 Co-infection with HIV.
Margriet den Boer, Luis Rivas, Jorge Alvar
.
-
8
Visceral leishmaniasis.
Shyam Sundar
,
J aya Chakravarty
.- 9 American Tegumentary leishmaniasis.
Olga Zerpa, Alicia Ponte-Sucre
.- IV Molecular features of drug-resistant
Leishmania
.- 10 Genetic expression and drug resistance, the role of proteomics.
Patricia Cuervo, Jose Batista de Jesus
.
-
11 The role of ABC transporters in drug-resistant
Leishmania. Adriano C Coelho
,
Paulo C Cotrim.-
12 Functional analysis of
Leishmania
membrane (non ABC) transporters involved in drug resistance.
Scott M Landfear
.- 13 Intracellular mechanisms of resistance in
Leishmania.-
V Pharmacology and chemotherapy of leishmaniasis.
Mitali Chatterjee
.- 14 Classical vs new Treatment regimens.
Louis Maes, Raquel Andreia Inocencio da Luz, Paul Cos, Vanessa Yardley
.- 15 Drug targets, drug effectors and drug targeting and delivery.
Philippe M Loiseau, Gillian Barratt
.- 16 Mechanisms of miltefosineresistance in
Leishmania. Francisco Gamarro,María P Sánchez-Cañete, Santiago Castanys.-
17 P-glycoprotein-like transporters in
Leishmania
: a search for reversal agents.
Bruno Pradines.
- VI Strategies to circumvent drug resistance in
Leishmania.-
18 The relevance of susceptibility tests, breakpoints and markers.
Louis Maes, Paul Cos and Simon Croft
.- 19 The Concept of Fitness and drug resistance in
Leishmania. Alicia Ponte-Sucre, Emilia Diaz, Maritza Padrón-Nieves.